Role of Hyaluronan-Mediated CD44 Signaling in Head and Neck Squamous Cell Carcinoma Progression and Chemoresistance
- 31 March 2011
- journal article
- review article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 178 (3), 956-963
- https://doi.org/10.1016/j.ajpath.2010.11.077
Abstract
No abstract availableKeywords
Funding Information
- Veterans Affairs
- VA Merit Review
- U.S. Public Health (R01 CA66163, R01 CA78633, P01 AR39448)
This publication has 49 references indexed in Scilit:
- CD44, a therapeutic target for metastasising tumoursEuropean Journal Of Cancer, 2010
- Reduction of Hyaluronan-CD44–Mediated Growth, Migration, and Cisplatin Resistance in Head and Neck Cancer Due to Inhibition of Rho Kinase and PI-3 Kinase SignalingJAMA Otolaryngology–Head & Neck Surgery, 2010
- Hyaluronan-CD44 Interactions in Cancer: Paradoxes and PossibilitiesClinical Cancer Research, 2009
- CD44 variant isoforms in head and neck squamous cell carcinoma progressionThe Laryngoscope, 2009
- Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progressionSeminars in Cancer Biology, 2008
- Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cellsSeminars in Cancer Biology, 2008
- OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcomeBritish Journal of Cancer, 2007
- Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinomaProceedings of the National Academy of Sciences of the United States of America, 2007
- Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlinOncogene, 2006
- Targeting epidermal growth factor receptor in head and neck cancerHead & Neck, 2002